SFDA Greenlights Groundbreaking Biotech Diagnostic Test for Early Alzheimer’s Detection
SFDA – Saudi Food and Drug Authority has authorized a pioneering biotechnology-based in vitro diagnostic test that detects Alzheimer’s disease at an early stage by measuring a specific biomarker in blood plasma. This innovation marks a significant breakthrough in medical diagnostics, greatly improving the early identification of neurodegenerative conditions. Introducing
